Promoters of influx healthtech held 1,70,23,464 equity shares as of March 31, 2026, and confirmed that no shares were encumbered during the financial year ended March 31, 2026. The disclosure was submitted by Promoter Munir Abdul Ganee Chandniwala to the National Stock Exchange on behalf of the promoter group. This declaration is in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulation, 2011.

The filing confirms that the promoter group did not create any charge or pledge on their shareholding, directly or indirectly, during FY26 other than those previously disclosed. The total shareholding includes stakes held by individual promoters and members of the promoter group. Munir Abdul Ganee Chandniwala holds the majority of these shares.

Shareholding Breakdown

The following table details the shareholding of the promoters and promoter group members as of March 31, 2026:

The disclosure was addressed to the Listing Department of the National Stock Exchange and copied to the Audit Committee of Influx Healthtech Limited. The promoter group includes individuals and corporate entities such as Olahey Wellness Private Limited.

Influx Healthtech Limited reported a financial performance for FY26 with revenue from operations reaching INR146 crores, a 41% year-on-year growth in H2 FY26. The company’s Profit After Tax (PAT) for the full year stood at INR20.5 crores, with a PAT margin of 14%. EBITDA for the year was INR29.9 crores, reflecting a margin of 20.3%.

Financial Highlights

The company’s operational efficiency improved as the cash conversion cycle reduced to 64 days in FY26 from the previous year. Inventory days decreased to 99 days from 112 days in FY25, while debtor days improved to 84 days from 113 days.

Operational Updates

Influx Healthtech commissioned a new granulation line for tablet manufacturing with a capacity of 480 kg per day. The company is developing a new facility of approximately 75,000 square feet, expected to be operational by July or August 2026. This expansion is anticipated to increase overall installed capacity by 2.5 times. Additionally, the company incorporated a wholly owned subsidiary, Olahey Wellness Private Limited, to manufacture ready-to-drink wellness beverages.

Future Guidance

The management stated that the company aims to grow by 25% to 30% in FY27 with similar margins. The Board has approved the reallocation of INR10 crores from IPO proceeds, primarily from surplus amounts, towards the enhanced construction cost for the nutraceutical CDMO facility.